Evidence map›Paper›PMID 27730210›Full record

ArticleScience advances2016

Maintenance of leukemic cell identity by the activity of the Polycomb complex PRC1 in mice.

Alessandra Rossi, Karin J Ferrari, Andrea Piunti, SriGanesh Jammula, Fulvio Chiacchiera, Luca Mazzarella, Andrea Scelfo, Pier Giuseppe Pelicci, Diego Pasini

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Alessandra RossiDepartment of Experimental Oncology, European Institute of Oncology, Milan, Italy.
Karin J FerrariDepartment of Experimental Oncology, European Institute of Oncology, Milan, Italy.
Andrea PiuntiDepartment of Experimental Oncology, European Institute of Oncology, Milan, Italy.ORCID 0000-0002-3344-8755
SriGanesh JammulaDepartment of Experimental Oncology, European Institute of Oncology, Milan, Italy.
Fulvio ChiacchieraDepartment of Experimental Oncology, European Institute of Oncology, Milan, Italy.
Luca MazzarellaDepartment of Experimental Oncology, European Institute of Oncology, Milan, Italy.
Andrea ScelfoDepartment of Experimental Oncology, European Institute of Oncology, Milan, Italy.
Pier Giuseppe PelicciDepartment of Experimental Oncology, European Institute of Oncology, Milan, Italy.; Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan, Italy.
Diego PasiniDepartment of Experimental Oncology, European Institute of Oncology, Milan, Italy.ORCID 0000-0002-9879-6486
European Institute of Oncology · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leukemia is a complex heterogeneous disease often driven by the expression of oncogenic fusion proteins with different molecular and biochemical properties. Whereas several fusion proteins induce leukemogenesis by activating

Indexed as

Gene Expression Regulation, LeukemicLeukemiaNeoplasm ProteinsPolycomb Repressive Complex 1AnimalsCell Line, TumorMiceMice, Inbred NODMice, SCIDNeoplasm ProteinsPolycomb Repressive Complex 1histone modificationsleukemiaMLL-AF9PolycombPRC1

Identifiers

PMID27730210
PMCPMC5055382
OpenAlexW2528017275

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.